Author, year | Country | Recruiting period | Population as reported | Age, mean (SD) | Sample size | Anti-HCV prevalence (%) (95% CI) | Risk of selection bias |
---|---|---|---|---|---|---|---|
MSM | |||||||
 Ireland, 2017 [39] | UK | 28 February - 15 December 2014 | MSM attending 4 genitourinary medicine clinics in Manchester | – | HIV+:735 HIV-:855 | 1.80 (−) 0.20 (−) | Low risk |
 Vanhommerig, 2013 [40] | Netherland | 2009–2012 | HIV-infected MSM during 5 waves of anonymous surveys at Amsterdam STI clinic | – | 439 | 7.10 (−) | High risk |
 Cotte, 2018 [41] | France | January 2016 to May 2017 | HIV+, HCV-negative MSM with serological follow-up in 2016 | – | HIV+:13051 HIV-:930 | 5.10 (−) 1.80 (−) | Low risk |
Prisoner | |||||||
 Ekeke, 2018 [42] | UK | December 2015-February 2017 | Prisoners entered Pentonville prison | – | 1324 | 7.00 (−) | High risk |
 Patel, 2016 [43] | UK | − | Inmates in a medium security prison | – | 160 | 33.75 (−) | High risk |
 Casella, 2016 [44] | Portugal | 2014 and 2016 | Inmates of 2 male prisons in the centre of Portugal (Pinheiro da Cruz and Setubal) | – | 82 | 38.00 (−) | High risk |
 Liberal, 2017 [45] | Portugal | January–April | Inmates from one of the largest prisons in Portugal | – | 1208 | 15.70* (−) | High risk |
 Svendsen, 2017 [46] | Norway | September 2015 | At-risk populations in Trondheim, Norway | – | 304 | 41.00 (−) | High risk |
 Lerena, 2016 [47] | Spain | − | Inmates in a Northern region of Spain (Cantabria) with 600 k inhabitants and focused on the regional long-stay prison of El Dueso | – | 436 | 16.00 (−) | High risk |